Related references
Note: Only part of the references are listed.A comprehensive review on glucokinase activators: Promising agents for the treatment of Type 2 diabetes
Ramasamy Thilagavathi et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2022)
Dorzagliatin in drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial
Dalong Zhu et al.
NATURE MEDICINE (2022)
Dorzagliatin add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial
Wenying Yang et al.
NATURE MEDICINE (2022)
Virtual screening web servers: designing chemical probes and drug candidates in the cyberspace
Natesh Singh et al.
BRIEFINGS IN BIOINFORMATICS (2021)
Interplay among Structural Stability, Plasticity, and Energetics Determined by Conformational Attuning of Flexible Loops in PD-1
Lovika Mittal et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2021)
Microsecond MD Simulation and Multiple-Conformation Virtual Screening to Identify Potential Anti-COVID-19 Inhibitors Against SARS-CoV-2 Main Protease
Chandrabose Selvaraj et al.
FRONTIERS IN CHEMISTRY (2021)
Elucidating the Glucokinase Activating Potentials of Naturally Occurring Prenylated Flavonoids: An Explicit Computational Approach
Kolade Olatubosun Faloye et al.
MOLECULES (2021)
Natural products in drug discovery: advances and opportunities
Atanas G. Atanasov et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Molecular Docking and Dynamics Simulation Revealed the Potential Inhibitory Activity of ACEIs Against SARS-CoV-2 Targeting the hACE2 Receptor
Ahmed A. Al-Karmalawy et al.
FRONTIERS IN CHEMISTRY (2021)
Rational Design of Novel Inhibitors of α-Glucosidase: An Application of Quantitative Structure Activity Relationship and Structure-Based Virtual Screening
Sobia Ahsan Halim et al.
PHARMACEUTICALS (2021)
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019
David J. Newman et al.
JOURNAL OF NATURAL PRODUCTS (2020)
Structure-Based Virtual Screening: From Classical to Artificial Intelligence
Eduardo Habib Bechelane Maia et al.
FRONTIERS IN CHEMISTRY (2020)
Decisions with Confidence: Application to the Conformation Sampling of Molecules in the Solid State
Paul C. D. Hawkins et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)
Design, synthesis and evaluation of novel 3,5-disubstituted benzamide derivatives as allosteric glucokinase activators
Ajmer Singh Grewal et al.
BMC CHEMISTRY (2019)
Design, synthesis and biological evaluation of novel thiazol-2-yl benzamide derivatives as glucokinase activators
Neha Charaya et al.
COMPUTATIONAL BIOLOGY AND CHEMISTRY (2018)
Dorzagliatin (HMS5552), a novel dual-acting glucokinase activator, improves glycaemic control and pancreatic β-cell function in patients with type 2 diabetes: A 28-day treatment study using biomarker-guided patient selection
Xiao-Xue Zhu et al.
DIABETES OBESITY & METABOLISM (2018)
Discovery of a potent glucokinase activator with a favorable liver and pancreas distribution pattern for the treatment of type 2 diabetes mellitus
Hiroki Fujieda et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Anthocyanins from purple corn activate free fatty acid-receptor 1 and glucokinase enhancing in vitro insulin secretion and hepatic glucose uptake
Diego A. Luna-Vital et al.
PLOS ONE (2018)
The Role of Natural Products in Drug Discovery and Development against Neglected Tropical Diseases
Peter Mubanga Cheuka et al.
MOLECULES (2017)
Using PyMOL as a platform for computational drug design
Shuguang Yuan et al.
WILEY INTERDISCIPLINARY REVIEWS-COMPUTATIONAL MOLECULAR SCIENCE (2017)
TMG-123, a novel glucokinase activator, exerts durable effects on hyperglycemia without increasing triglyceride in diabetic animal models
Yoshinori Tsumura et al.
PLOS ONE (2017)
Identification of mangiferin as a potential Glucokinase activator by structure-based virtual ligand screening
Qiuxia Min et al.
SCIENTIFIC REPORTS (2017)
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
Antoine Daina et al.
SCIENTIFIC REPORTS (2017)
Pyridoxine dipharmacophore derivatives as potent glucokinase activators for the treatment of type 2 diabetes mellitus
Mikhail S. Dzyurkevich et al.
SCIENTIFIC REPORTS (2017)
Novel, highly potent systemic glucokinase activators for the treatment of Type 2 Diabetes Mellitus
Jiayi Xu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Multiple Comparisons of Glucokinase Activation Mechanisms of Five Mulberry Bioactive Ingredients in Hepatocyte
Hao He et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2016)
Structural analysis of protein-ligand interactions: the binding of endogenous compounds and of synthetic drugs
Anna M. Gallina et al.
JOURNAL OF MOLECULAR RECOGNITION (2014)
Molecular Dynamics Simulation by GROMACS Using GUI Plugin for PyMOL
Tomasz Makarewicz et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2013)
Molecular docking studies for the identification of novel melatoninergic inhibitors for acetylserotonin-O-methyltransferase using different docking routines
Syed Sikander Azam et al.
THEORETICAL BIOLOGY AND MEDICAL MODELLING (2013)
Control of beta cell function and proliferation in mice stimulated by small-molecule glucokinase activator under various conditions
A. Nakamura et al.
DIABETOLOGIA (2012)
FRED and HYBRID docking performance on standardized datasets
Mark McGann
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2012)
Definition and testing of the GROMOS force-field versions 54A7 and 54B7
Nathan Schmid et al.
EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS (2011)
FRED Pose Prediction and Virtual Screening Accuracy
Mark McGann
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2011)
Designing glucokinase activators with reduced hypoglycemia risk: discovery of N,N-dimethyl-5-(2-methyl-6-((5-methylpyrazin-2-yl)-carbamoyl)benzofuran-4-yloxy)pyrimidine-2-carboxamide as a clinical candidate for the treatment of type 2 diabetes mellitus
Jeffrey A. Pfefferkorn et al.
MEDCHEMCOMM (2011)
Lipophilicity in drug discovery
Michael J. Waring
EXPERT OPINION ON DRUG DISCOVERY (2010)
Conformer Generation with OMEGA: Algorithm and Validation Using High Quality Structures from the Protein Databank and Cambridge Structural Database
Paul C. D. Hawkins et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2010)
Crizotinib in ALK-Rearranged Inflammatory Myofibroblastic Tumor
James E. Butrynski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Molecular Physiology of Mammalian Glucokinase
P. B. Iynedjian
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Generation of a set of simple, interpretable ADMET rules of thumb
M. Paul Gleeson
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro
LL Chen et al.
JOURNAL OF VIROLOGY (2005)
A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): Relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells
ER Wood et al.
CANCER RESEARCH (2004)
Classification analysis of P-glycoprotein substrate specificity
R Didziapetris et al.
JOURNAL OF DRUG TARGETING (2003)
Zanamivir: from drug design to the clinic
M Elliott
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2001)
Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties
P Ertl et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Share Paper
